DJIA 16,399.67 19.26 0.12%
NASDAQ 4,316.07 57.64 1.35%
S&P 500 1,904.01 17.25 0.91%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)



company name or ticker
Company Photos
(Click to zoom)

Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog

Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?

The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?

Ironwood/Actavis Move Linzess into Phase II Study for OIC - Analyst Blog

Ironwood/Actavis Move Linzess into Phase II Study for OIC - Analyst Blog

AstraZeneca (AZN) Lagging In Pre-Market Activity

A Quick Look at Amgen, Inc.'s Drug Development Pipeline

Amgen's drug development pipeline is expected to deliver data on 10 late-stage candidates between 2014 and 2016. Find out what three studies are Amgen's most critical, as well as whether or not Amgen stock has the potential to head higher.

Today's Market: Inversions, Tech Deals And Upgrades/Downgrades Moving These Names

European Stocks Lower on Banking Contractions

AbbVie (ABBV) May Not Buy Shire (SHPG), But You Should

European Stocks Fall on Continued Worries Over Eurozone Economy

Pfizer's Breast Cancer Candidate Gets Priority Review - Analyst Blog

Pfizer's Breast Cancer Candidate Gets Priority Review - Analyst Blog
See More Articles...